Pioglitazone
- Product NDC
- 50090-4556
- 11-digit product format
- 500904556
- Labeler code
- 50090
- Product ID
- 50090-4556_1cea87f3-5b88-4cb2-80f4-651c3a1155e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA200268
- Marketing category
- ANDA
- Marketing start
- 2013-02-13
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-4556-0 | 50090455600 | 30 TABLET in 1 BOTTLE (50090-4556-0) | 30 tablet | 2019-09-25 | 0000-00-00 | No | No | Current |
| 50090-4556-1 | 50090455601 | 90 TABLET in 1 BOTTLE (50090-4556-1) | 90 tablet | 2019-09-25 | 0000-00-00 | No | No | Current |